Midwest Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$759K Buy
4,698
+1,585
+51% +$264K 0.01% 402
2026
Q2
$590K Buy
3,113
+562
+22% +$106K 0.01% 419
2026
Q1
$503K Buy
+2,551
New +$492K 0.01% 439

Other funds holding AZN

Midwest Trust's AZN Position: Q3 2026 in Review

Midwest Trust increased its AstraZeneca (AZN) stake by 51% in Q3 2026, buying an estimated $264K and bringing the position to 4,698 shares worth $759K. The position accounts for 0.01% of the portfolio, ranked #402.

Midwest Trust first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. 479 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Midwest Trust held 4,698 shares of AstraZeneca worth $759K as of Q3 2026.
  • Midwest Trust bought 1,585 AstraZeneca shares in Q3 2026, an estimated $264K.
  • AstraZeneca made up 0.01% of Midwest Trust's portfolio in Q3 2026, its #402 holding.
  • Midwest Trust first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • 479 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.